BSE smallcap pharma agency declares 1st interim dividend for FY26 in Q2 outcomes — Examine file date

A small-cap pharmaceutical firm has introduced its Q2 FY26 outcomes for the quarter and half-year ended September 30, 2025.

Together with quarterly outcomes, the pharma firm has introduced the primary interim dividend of 1,400 per cent for its shareholders for the monetary 12 months 2025–26.

The corporate has additionally introduced the file date and the cost date for the dividend. The corporate below dialogue is Ajanta Pharma.

Ajanta Pharma Dividend Payout

The corporate’s Board of Administrators has permitted the primary interim dividend of Rs 28 per share on the face worth of Rs 2 every, which interprets to 1400 per cent dividend payout amounting to a complete payout of round Rs 350 crore.

The corporate has mounted Monday, tenth November 2025, because the file date for cost of the first interim dividend. Dividend shall be paid on or after twentieth November 2025.

For the second quarter of FY26, income from operations elevated 14 per cent to Rs 1,354 crore, in contrast with Rs 1,187 crore in the identical interval final 12 months. EBITDA stood at Rs 328 crore, up 5 per cent year-on-year, with a margin of 24 per cent. Revenue after tax (PAT) rose 20 per cent to Rs 260 crore, in opposition to Rs 216 crore in Q2 FY25.

The corporate recorded a mark-to-market international change lack of Rs 41 crore through the quarter. Excluding this impression, EBITDA was Rs 369 crore, up 9 per cent, with a margin of 27 per cent, whereas PAT grew 23 per cent, with a margin of twenty-two per cent.

Ajanta Pharma is a part of the BSE 500 index and has a market capitalisation of Rs 31,071.49 crore. Over the past 5 years, the inventory has gained 131.69 per cent, displaying constant long-term development.

Presently, the inventory is buying and selling Rs 2500 ranges. The share value has moved between a 52-week excessive of Rs 3,147.90 and a low of Rs 2,022.05.

The corporate has maintained a gentle dividend observe file, declaring Rs 28 per share on November 6, 2024, Rs 26 per share on February 8, 2024, and Rs 10 and Rs 15 per share on August 4, 2023.

Ajanta Pharma has additionally issued bonus shares in a 1:2 ratio twice on June 22, 2022, and as soon as earlier on September 17, 2013.